Paying users zone. Data is covered by .

  • Get to Biogen Inc. for $15.99, or

  • get to whole website for at least 3 months from $49.99.

$15.99

Statement of Cash Flows Quarterly Data

Difficulty: Beginner

The cash flow statement provides information about a company's cash receipts and cash payments during an accounting period, showing how these cash flaws link the ending cash balance to the beginning balance shown on the company's statement of financial position.

The cash flow statement consists of three parts: cash flows provided by (used in) operating activities, cash flows provided by (used in) investing activities, and cash flows provided by (used in) financing activities.

Biogen Inc., Consolidated Statement of Cash Flows (quarterly data)

USD $ in thousands

 
3 months ended Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015 Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014 Dec 31, 2013 Sep 30, 2013 Jun 30, 2013 Mar 31, 2013
Net income
Depreciation and amortization
Acquired in-process research and development
Share-based compensation
Deferred income taxes
Contingent consideration
Other
Accounts receivable
Inventory
Accrued expenses and other current liabilities
Income tax assets and liabilities
Other changes in operating assets and liabilities, net
Changes in operating assets and liabilities, net
Adjustments to reconcile net income to net cash flows from operating activities
Net cash flows provided by operating activities
Proceeds from sales and maturities of marketable securities
Purchases of marketable securities
Contingent consideration paid related to Fumapharm AG acquisition
Purchases of property, plant and equipment
Acquired in-process research and development
Acquisitions of intangible assets
Acquisitions of business, net of cash acquired
Purchases of reverse repurchase agreements
Acquisition of TYSABRI rights
Other
Net cash flows (used in) provided by investing activities
Purchases of treasury stock
Proceeds from (payments related to) issuance of stock for share-based compensation arrangements, net
Net distribution to noncontrolling interest
Net cash contribution to Bioverativ Inc.
Proceeds from borrowings
Repayment of borrowings
Proceeds from (repayments of) borrowings under line of credit facility
Contingent consideration payments
Excess tax benefit from share-based awards
Other
Net cash flows provided by (used in) financing activities
Effect of exchange rate changes on cash and cash equivalents
Net increase (decrease) in cash and cash equivalents
Source: Biogen Inc., Quarterly and Annual Reports
Item Description The company
Net cash flows provided by operating activities The net cash from (used in) all of the entity's operating activities, including those of discontinued operations, of the reporting entity. Operating activities generally involve producing and delivering goods and providing services. Operating activity cash flows include transactions, adjustments, and changes in value that are not defined as investing or financing activities. Biogen Inc.'s net cash flows provided by operating activities declined from Q3 2017 to Q4 2017 and from Q4 2017 to Q1 2018.

Top